MJ
Therapeutic Areas
AcuraStem Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AS-241 (UNC13A ASO) | ALS / FTD | Pre-clinical |
| PIKFYVE Program | ALS / FTD | Pre-clinical |
| SYF2 Program | ALS | Discovery |
Leadership Team at AcuraStem
SA
Sam Alworth, MS, MBA
Co-founder and CEO
MV
Marcel van der Brug, Ph.D.
Chief Scientific Officer
WC
Wen-Hsuan Chang, PhD
Associate Vice President, Discovery and Early Development
JI
Justin Ichida, PhD
Co-founder, Scientific Collaborator (Assoc. Prof., USC)